Predictive role of neostromal CD10 expression in breast cancer patients treated with neoadjuvant chemotherapy
Background: The therapeutic strategy of invasive breast cancer is based on routine histopathological markers (estrogen-, progesterone receptor, HER2, Ki67) routinely evaluated in tumor cells. However, the assessment of cancer stroma could influence therapeutic strategies. Studies have shown that str...
Saved in:
Main Authors: | Orsolya Olah (Author), Edit Majlat (Author), Renata Koszo (Author), Zoltan Vereb (Author), Andras Voros (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CD4+ Tumor-infiltrating Lymphocytes in Neoadjuvant Chemotherapy-treated Invasive Breast Cancer of No Special Type
by: Primariadewi Rustamadji, et al.
Published: (2024) -
Evaluation of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
by: Wang H, et al.
Published: (2020) -
Lapatinib, trastuzumab or the combination added to neoadjuvant chemotherapy for breast cancer
by: Quan Liang, et al.
Published: (2016) -
Evaluation of Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Experience in a Single Institution over a 10-Year Period
by: Misun Choi, et al.
Published: (2017) -
Neoadjuvant Chemotherapy Current Applications in Clinical Practice
Published: (2012)